We further validated the decreased protein expression of MHC-I, B2M, and MHC-II by IHC in PRC2-loss tumors using an MPNST tissue microarray (TMA) (Figure 2, C and D). This evidence concerns the gene B2M and malignant peripheral nerve sheath tumor.